involved in the regulation of cell death. Palmitate was reported to induce apoptosis of cardiomyocytes through either the PI3K/ AKT or AMPK signaling pathway (20, 21) . In models of bacterial lipopolysaccharide induction, a reactive oxygen species (ROS)-dependent pathway was found to be regulated by miR-146a (22) . Furthermore, the expression of 23 miRNAs was altered after H 2 O 2 treatment in normal human fibroblasts (23) . All these observations indicate that the expression of miRs play a significant role in fatty acid-induced apoptosis. However, few studies have focused on the exact mechanism of how certain miRs work. In the present study, we employ a model of palmitate-induced cardiomyocyte apoptosis to explore whether miR-21 is related to the regulation of cell death and to investigate a possible underlying mechanism.
Methods
Cell culture H9c2 embryonic rat heart-derived cells were obtained from Academia Sinica (Shanghai, China). Cells were cultured in DMEM containing 15% FBS, 100 U/mL penicillin, and 100 µg/mL streptomycin at 37°C in a humidified atmosphere of 5% CO 2 .
Cell viability assay H9c2 cells were seeded at a density of 5×10 3 cells/well in 96-well plates, and cell viability was determined using the MTT assay. The cells were incubated with palmitate at various concentrations (0.2, 0.4, and 0.6 mM) for 12, 18, and 24 h. Following palmitate incubation, each well was washed twice with PBS to remove the medium before 10 µL 0.5 mg/mL MTT was added to each well and incubated for an additional 4 h at 37°C. The absorbance at 490 nm was read on a microplate reader and used as a measurement of cell viability. The absorbance was normalized to cells incubated in control medium, which were considered 100% viable.
Flow cytometry
Apoptotic cells were detected using the Annexin V-FITC/ propidium iodide kit (Vazyme Biotech, Nanjing, China) according to the manufacturer's instructions. In brief, the palmitate-treated cells were washed twice with PBS and dislodged using 0.25% trypsin. Cells were centrifuged and resuspended in PBS containing 50 µg/mL propidium iodide, 0.1 g/L RNase, and 1% bovine serum albumin. The cells were then incubated at 37°C for 30 min in the dark before analysis.
Western blot analysis
Cell lysates were prepared and 20 µg of these were separated by 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to nitrocellulose membranes. , and monoclonal anti-β-actin (CST, SN: 8457, dilution: 1:4000) antibodies were used. HRP-conjugated immunoglobulin was used as the secondary antibody (Jackson ImmunoResearch Laboratories, West Grove, PA, USA). West Pico chemiluminescence was used as the substrate to visualize protein bands, which were quantified using densitometric image analysis software (Image Master VDS; Pharmacia Biotech) and normalized to β-actin expression.
Reverse transcription-polymerase chain reaction (RT-PCR) Total RNA was isolated using the Trizol reagent (Invitrogen, San Diego, CA, USA). The first strand of cDNA was synthesized using a reverse transcription kit (PrimeScript™ Synthesis kit, Takara Bio, Inc., Dalian, China). RT-PCR was performed using the SYBR Premix Ex Taq Kit (Takara Bio, Inc., Dalian, China) on an Applied Biosystems 7500 Real-Time PCR system (Applied Biosystems, White Plains, NY, USA). β-actin was used as an internal control. The experiment was performed in triplicates. Primers for miR-21 were designed and synthesized by Invitrogen China.
ROS detection ROS production was measured using an ELISA kit (Vazyme Biotech) according to the manufacturer's instructions. Measurements are given as fold changes compared with control.
Statistical analysis
Experimental results are presented as the mean ± standard deviation. Comparisons between two groups were conducted using the two-tailed Student's t-test or the Chi square test (SPSS 18.0, Chicago, IL, USA). The comparison of multiple groups was analyzed using ANOVA with Holm-Sidak's or Dunnett's multiple comparisons test (GraphPad Prism 6.0, La Jolla, CA, USA). Differences were considered statistically significant when the p value was <0.05.
Results
Palmitate inhibits H9c2 proliferation and induces H9c2 apoptosis H9c2 was exposed to 0.2, 0.4, 0.6, and 0.8 mM palmitate for 12, 18, and 24 h. Significant differences in cell viability were detected at 0.4 and 0.6 mM palmitate exposure for 18 and 24 h when compared with controls, which had not been treated with palmitate (Fig. 1a, Table 1-3) . The apoptosis rate of H9c2 cells was measured after 24 h of exposure to 0.4 and 0.6 mM palmitate. The rate significantly increased in response to both concentrations compared with control, but there was no significant difference in the apoptosis rate between the two concentrations (Fig. 1b,  Table 1-3) . Based on this, 0.4 mM palmitate for 24 h was used as the exposure condition in subsequent experiments. In addition, both the expression of cleaved caspase-3 and caspase-3 activity (3-fold) was increased, whereas Bcl-2 expression was inhibited, compared with the β-actin internal control after 24 h of exposure to palmitate (Fig. 1c and 1d, Table 1-3) .
Role of miR-21 in palmitate-induced H9c2 cell apoptosis Compared with an internal control, miR-21 expression was reduced almost 3-fold after 24 h of exposure to 0.4 mM palmitate Effect of miR-21 on Bcl-2 expression and ROS production Bcl-2 protein expression was higher in H9c2 cells that were transfected with the miR-21 mimic in combination with palmitate mM N acetylcysteine (NAC, an antioxidant agent) significantly inhibited apoptosis, DNA fragmentation, and cleaved caspase-3 expression in H9c2 cells exposed to palmitate (Fig. 3d, 3e , and 3f, Table 7 -12). 
Scrambled oligo Mimic
MiR-21 affects nuclear factor κB pathway on palmitate-induced H9c2 cell apoptosis After 24 h of exposure to palmitate, the expression of p65, a key proinflammatory component of the nuclear factor κB (NF-κB) pathway in the nucleus, was significantly increased (Fig. 4a,  Table 13-19 ). The overexpression of miR-21 did not affect the expression levels of p65 either in the nucleus or in the cytoplasm but did completely suppress the increase of nuclear p65 expression after exposure to palmitate (Fig. 4a, Table 13-19) . No significant change in phosphorylated mitogen-activated protein kinase (MAPK) p38 (p-p38), a marker of inflammation and apoptosis, was observed in H9c2 cells transfected with the miR-21 mimic (Fig.  4b, Table 13-19) . However, miR-21 suppressed the upregulation of p-p38 expression after exposure to palmitate (Fig. 4b, Table 13-19 ). Without palmitate stimulus, a p38 inhibitor had no effect on the expression of Bcl-2 or cleaved caspase-3 in H9c2 cells. When palmitate was included, the p38 inhibitor induced Bcl-2 expression and inhibited caspase-3 activity (Fig. 4c, Table 13-19) . The p38 inhibitor did not induce apoptosis, ROS production, or DNA fragmentation in H9c2 cells; however, in the presence of palmitate, the p38 inhibitor reduced apoptosis, ROS production, and DNA fragmentation (Fig. 4d-4f, Table 13-19 ). 
Discussion
It is well known that the loss of cardiomyocytes is a major factor that contributes to cardiac dysfunction and heart failure (24) . Inhibition of cardiomyocyte apoptosis is a potential strategy to prevent the development of heart failure (25) . In many heart diseases, saturated fatty acids were found to play a key role in myocardial injury, a consequence of cardiomyocyte apoptosis (26) (27) (28) . Large amounts of palmitate, a key saturated fatty acid, can accumulate in cardiomyocytes and induce apoptosis (29) ; however, the exact pathway of palmitate-induced apoptosis is yet to be determined. MiRs are involved in the regulation of gene transcription. They can specifically recognize and target the 3′ non-coding region of mRNA at the transcriptional level, causing degradation or inhibition of mRNA translation, thereby regulating gene expression. An altered gene regulation plays an important role in the occurrence and development of various diseases (30) . In the heart, miRs have been found to regulate various pathophysiological processes, including cardiac remodeling, cardiac development, myocardial fibrosis, angiogenesis, and cardiomyocyte apoptosis (31) . In terminally differentiated cells, such as cardiomyocytes, regulation of apoptosis is crucial because inadequate or excessive apoptosis can lead to atherosclerosis, myocardial infarction, heart failure, and other cardiovascular diseases (32) .
It has been found in recent years that miR-21 is highly expressed in vascular smooth muscle cells, vascular endothelial cells, cardiomyocytes, and cardiac fibroblasts. The levels of miR-21 expression have been shown to be altered in various cardiovascular diseases, indicating that miR-21 is involved in the occurrence and development of cardiovascular diseases (33) (34) (35) (36) . Studies have confirmed that miR-21 is an apoptosis-related miR, which regulates cell cycle (37, 38). Sayed et al. established a model of cardiomyocyte apoptosis by continuous hypoxia and observed the downregulation of miR-21 and upregulation of FasL, which was reversed by AKT activation. However, the overexpression of miR-21 inhibited upregulation of PTEN and FasL and increased the levels of phosphorylated AKT, leading to reduced infarct size and alleviation of heart failure (39). In the work presented here, we induced apoptosis in H9c2 cells by addition of 0.4 and 0.6 mM palmitate. The apoptosis rate was significantly higher than that in the non induced control group. Moreover, palmitate increased the expression of cleaved caspase-3 and decreased the expression of Bcl-2, indicating that the caspase and Bcl-2/Bax pathways might be involved. Bcl-2 and caspase-3 are two classic markers of apoptosis. The Bcl-2 family of genes affects mitochondrial transmembrane potential and has been extensively studied. The antiapoptotic gene Bcl-2 and the proapoptotic gene Bax are two representative members of the Bcl-2 family. Bcl-2 was the first gene found to inhibit apoptosis (40) . High expression of Bcl 2 helps maintain stability of the mitochondrial membrane potential by keeping the mitochondrial permeability transition pore in a closed state, preventing the release of mitochondrial apoptotic proteins, and subsequently cell apoptosis. The caspase family of genes plays an essential role in mediating cell apoptosis, among which caspase-3 is the main executor of cell apoptosis and can be activated by various upstream factors (41) (42) (43) (44) . Activated caspase-3 induces the activation of other caspase members in a protease cascade, which ultimately leads to apoptosis (45) . Studies have shown that miR-21 overexpression could inhibit H2O2-induced apoptosis of cardiomyocytes by downregulating the expression of PDCD4 (46), a protective effect also observed in hypoxia/reoxygenation-induced cell apoptosis and in rat hearts after ischemia/reperfusion injury in vivo (37) . In the present study, we found that the overexpression of a miR-21 mimic could inhibit the apoptosis induced by palmitate, whereas the low expression of miR-21 accelerated the process. ROS production and DNA fragmentation, which correlate with the apoptosis, were detected in the cells. The downregulation of miR-21 in cardiomyocyte apoptosis has been reported by other groups and has been shown to correlate with increased expression of FasL protein. It was also found that the expression of miR-21 in cardiac fibroblasts was significantly higher than that in normal cardiomyocytes. In the stress state, the expression of miR-21 in cardiac fibroblasts can significantly activate extracellular signal regulated kinase (ERK)/MAPK pathway proteins and promote the proliferation of fibroblasts and fibrosis (47) . Our work has demonstrated a new pathway by which miR-21 regulates apoptosis in cardiomyocytes, namely through the caspase-3/NF-κB pathway. NF-κB is an inducible transcription factor responsible for the expression of various genes involved in inflammation, injury, apoptosis, embryonic development, and proliferation (48, 49) . As the main functional element, p65 is involved in the regulation of various physiological and pathophysiological events (50) (51) (52) . We showed that p65 expression level in the nucleus increased by the exposure to palmitate, which was inhibited by miR-21. The overexpression of miR-21 did not affect the expression levels of p65 either in the nucleus or in the cytoplasm but did completely suppress the increase of nuclear p65 expression after exposure to palmitate. A combination of palmitate and a p38 inhibitor induced Bcl-2 expression and reduced caspase-3 activity. In addition, the p38 inhibitor reduced palmitate-induced apoptosis, suggesting that p38 is a key factor in cardiomyocyte apoptosis. Additionally, p38 is one of the first identified transcription factors, which is regulated by phosphorylation; p38 is involved in various pathophysiological processes, including cell growth, proliferation, differentiation, and apoptosis, by regulating the expression of many downstream target genes. Phospho-p38 causes cardiomyocyte damage by promoting inflammation and cell apoptosis. Studies have shown that p38 can be activated by various inflammatory factors, including oxygen free radicals released after myocardial ischemia/reperfusion injury and calcium overload. p38 activation induces expression of some early genes, such as c-fos, c-jun, and NF-κB (53, 54) , which upregulates the expression of cytokines, such as TNF-α, IL-1, and IL-8, leading to secondary myocardial damage (55) (56) (57) . We also observed alterations of ROS and the amount of DNA fragmentation in H9c2 cells. ROS can activate several pro-apoptotic signaling pathways, such as MAPK p38, c-Jun N-terminal kinase, apoptosis signal regulating kinase 1, and ERK (58) .
Study limitations
For this study, we used the embryonic rat heart-derived cellline H9c2. The link between apoptosis and the miR-21/caspase-3/ NF-κB pathways makes these pathways promising as therapeutic targets for heart disease; however, the findings need further study and validation in in vivo experiments and human cells to confirm the potential therapeutic benefit.
Conclusion
In summary, miR-21 protects cardiomyocytes from apoptosis induced by palmitate through the caspase-3/NF-κB pathway.
